Literature DB >> 9571528

Case-control study of idiopathic pulmonary fibrosis and environmental exposures.

J Mullen1, M J Hodgson, C A DeGraff, T Godar.   

Abstract

The authors conducted a matched case-control study of interstitial lung disease (ILD) using a self-administered questionnaire. All cases in the practice of two pulmonary specialists were identified. Cases were excluded if they were thought to have occupational exposures as a contributor, hypersensitivity pneumonitis or sarcoidosis, or some other well-recognized cause. Three controls were matched by sex and age (one year) as identified through orthopedic surgeons at the same institutions. Two rounds of a questionnaire were mailed; 17 cases (37.7%) and 94 controls (32.4%) responded to the questionnaire, although many of the case addresses were no longer valid. Individuals with ILD were 16.0 times as likely to report mold exposure and 11.1 times as likely to report silica as were controls in their workplace. Odds ratios associating ILD with moisture indicators in the home were in the same range as previously published associations between such indicators and wheezing. ILD may have environmental and occupational causes that warrant more systematic exploration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9571528     DOI: 10.1097/00043764-199804000-00011

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  9 in total

1.  Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study.

Authors:  David J Lederer; Paul L Enright; Steven M Kawut; Eric A Hoffman; Gary Hunninghake; Edwin J R van Beek; John H M Austin; Rui Jiang; Gina S Lovasi; R Graham Barr
Journal:  Am J Respir Crit Care Med       Date:  2009-06-19       Impact factor: 21.405

Review 2.  New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis.

Authors:  Qiang Ding; Tracy Luckhardt; Louise Hecker; Yong Zhou; Gang Liu; Veena B Antony; Joao deAndrade; Victor J Thannickal
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

3.  A Fulvic Acid-like Substance Participates in the Pro-inflammatory Effects of Cigarette Smoke and Wood Smoke Particles.

Authors:  David H Gonzalez; Joleen M Soukup; Michael C Madden; Michael Hays; Jon Berntsen; Suzanne E Paulson; Andrew J Ghio
Journal:  Chem Res Toxicol       Date:  2020-03-27       Impact factor: 3.739

4.  Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses.

Authors:  Yeonkyung Park; Chiwon Ahn; Tae-Hyung Kim
Journal:  Sci Rep       Date:  2021-03-02       Impact factor: 4.379

Review 5.  Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations.

Authors:  Carla R Copeland; Bridget F Collins; Margaret L Salisbury
Journal:  Chest       Date:  2021-02-18       Impact factor: 10.262

Review 6.  The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement.

Authors:  Paul D Blanc; Isabella Annesi-Maesano; John R Balmes; Kristin J Cummings; David Fishwick; David Miedinger; Nicola Murgia; Rajen N Naidoo; Carl J Reynolds; Torben Sigsgaard; Kjell Torén; Denis Vinnikov; Carrie A Redlich
Journal:  Am J Respir Crit Care Med       Date:  2019-06-01       Impact factor: 21.405

7.  Idiopathic pulmonary fibrosis and occupational risk factors.

Authors:  Silvia Ranzieri; Elisa Illica Magrini; Paola Mozzoni; Roberta Andreoli; Giovanna Pelà; Giuseppina Bertorelli; Massimo Corradi
Journal:  Med Lav       Date:  2019-12-17       Impact factor: 1.275

Review 8.  Human lung injury following exposure to humic substances and humic-like substances.

Authors:  Andrew J Ghio; Michael C Madden
Journal:  Environ Geochem Health       Date:  2017-08-01       Impact factor: 4.609

Review 9.  Epidemiology of idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Harold R Collard
Journal:  Clin Epidemiol       Date:  2013-11-25       Impact factor: 4.790

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.